ATLASFrench Stocks Fair Value: LOréal, LVMH Moët Hennessy - Louis Vuitton, TotalEnergies…
Of the 55 French companies below that have an ATLAS fair value estimate, 36 trade more than 8% below the model's central estimate, 6 within 8% of it and 13 more than 8% above it (median: price 28% below fair value). LOréal is the largest (market cap $239B); 49 of the 60 pay a dividend, with a median yield of 3.3%.
Updated Nov 3, 2026 · Source: EODHD / ATLAS model
| # | Company | Price | ATLAS fair value | Price vs fair value |
|---|---|---|---|---|
| 1 | LOréalOR.PA | €436.50 | €249.04 | +75% |
| 2 | LVMH Moët Hennessy - Louis VuittonMC.PA | €393.65 | €590.80 | -33% |
| 3 | TotalEnergiesTTE.PA | €83.61 | €96.21 | -13% |
| 4 | AirbusAIR.PA | €196.08 | €170.44 | +15% |
| 5 | Schneider Electric S.E.SU.PA | €240.45 | €129.32 | +86% |
| 6 | Hermes InternationalRMS.PA | €1,321 | €1,149 | +15% |
| 7 | SafranSAF.PA | €288.20 | €309.51 | -6.9% |
| 8 | Air LiquideAI.PA | €182.04 | €164.24 | +11% |
| 9 | BNP ParibasBNP.PA | €87.04 | €155.15 | -44% |
| 10 | AXACS.PA | €42.97 | €82.61 | -48% |
| 11 | SanofiSAN.PA | €80.63 | €179.57 | -55% |
| 12 | Christian DiorCDI.PA | €427.00 | ||
| 13 | EssilorLuxottica S. A.EL.PA | €186.90 | €276.75 | -32% |
| 14 | EngieENGI.PA | €23.46 | €22.04 | +6.4% |
| 15 | VinciDG.PA | €110.30 | €174.52 | -37% |
| 16 | Credit AgricoleACA.PA | €14.94 | €26.67 | -44% |
| 17 | ThalesHO.PA | €232.00 | €393.55 | -41% |
| 18 | Societe GeneraleGLE.PA | €61.50 | €90.41 | -32% |
| 19 | DanoneBN.PA | €66.06 | €69.01 | -4.3% |
| 20 | OrangeORA.PA | €14.49 | ||
| 21 | LegrandLR.PA | €132.85 | €114.05 | +16% |
| 22 | Compagnie de Saint-GobainSGO.PA | €70.40 | €158.12 | -55% |
| 23 | Dassault SystemesDSY.PA | €25.62 | €29.43 | -13% |
| 24 | KeringKER.PA | €179.66 | €298.82 | -40% |
| 25 | Publicis GroupePUB.PA | €101.00 | €172.14 | -41% |
| 26 | Veolia Environnement VEVIE.PA | €33.01 | €24.92 | +32% |
| 27 | Compagnie Generale des Etablissements MichelinML.PA | €32.63 | €43.21 | -24% |
| 28 | Dassault AviationAM.PA | €304.20 | €454.47 | -33% |
| 29 | Sartorius Stedim BiotechDIM.PA | €224.20 | €128.68 | +74% |
| 30 | CapgeminiCAP.PA | €126.90 | €183.44 | -31% |
| 31 | AmundiAMUN.PA | €93.00 | €98.46 | -5.5% |
| 32 | Pernod RicardRI.PA | €68.92 | €117.01 | -41% |
| 33 | BouyguesEN.PA | €41.14 | €63.00 | -35% |
| 34 | Eurofins ScientificERF.PA | €88.02 | €89.13 | -1.2% |
| 35 | Unibail-Rodamco-WestfieldURW.PA | €92.88 | €157.45 | -41% |
| 36 | Bureau VeritasBVI.PA | €29.20 | €35.27 | -17% |
| 37 | IpsenIPN.PA | €155.40 | €404.20 | -62% |
| 38 | CarrefourCA.PA | €13.05 | ||
| 39 | RexelRXL.PA | €35.07 | €36.71 | -4.5% |
| 40 | Accor S. A.AC.PA | €47.50 | €80.07 | -41% |
| 41 | Aeroports de ParisADP.PA | €114.80 | €198.69 | -42% |
| 42 | GetlinkGET.PA | €19.92 | €11.49 | +73% |
| 43 | BolloreBOL.PA | €3.78 | €1.92 | +97% |
| 44 | KlepierreLI.PA | €35.74 | €49.74 | -28% |
| 45 | BiomerieuxBIM.PA | €90.40 | €113.50 | -20% |
| 46 | EiffageFGR.PA | €102.85 | €236.39 | -56% |
| 47 | SodexoSW.PA | €59.85 | €99.64 | -40% |
| 48 | Gaztransport & Technigaz SASGTT.PA | €184.60 | €118.98 | +55% |
| 49 | RenaultRNO.PA | €27.80 | €82.91 | -66% |
| 50 | AlstomALO.PA | €11.69 | €13.66 | -14% |
| 51 | AbivaxABVX.PA | €76.05 | ||
| 52 | SPIESPIE.PA | €44.14 | €28.05 | +57% |
| 53 | AyvensAYV.PA | €9.20 | €26.02 | -65% |
| 54 | EdenredEDEN.PA | €23.92 | €31.87 | -25% |
| 55 | SCORSCR.PA | €34.18 | €50.37 | -32% |
| 56 | NexansNEX.PA | €120.80 | €138.09 | -13% |
| 57 | ElisELIS.PA | €23.72 | €53.05 | -55% |
| 58 | JC DecauxDEC.PA | €24.54 | €13.06 | +88% |
| 59 | SoitecSOI.PA | €124.30 | ||
| 60 | VallourecVK.PA | €18.64 | €41.94 | -56% |
Price vs fair value = latest close ÷ ATLAS fair value − 1: negative means the price is below the model's central estimate, positive above. Ordered by market capitalization. Prices and fair values are in each company's trading currency.
How this list is built
Ranking: companies are ordered by market capitalization in US dollars (EODHD). Investment funds and trusts and duplicate share classes are removed. ATLAS publishes 178 companies (France); the 60 largest are shown.
Fair value: ATLAS estimates a fair value per share every night with its valuation model (discounted cash flow and/or sector multiples, depending on the company), with a low–high range and a low, medium or high confidence label. Latest model run: Nov 2, 2026.
Price vs fair value is a description of the model, not a forecast and not a recommendation to buy or sell. Models can be wrong; a price below the estimate can stay there. Dividend yield is the forward yield reported by EODHD.
Frequently asked questions
Are French stocks undervalued?
ATLAS does not give a verdict: it compares each price with its own fair value estimate. As of Nov 3, 2026, of the 55 French companies with an estimate, 36 trade more than 8% below the model's central estimate, 6 within 8% and 13 more than 8% above (median: price 28% below fair value). This describes a model, not a forecast.
How does ATLAS estimate the fair value of European stocks?
Every night the ATLAS valuation model estimates a fair value per share (discounted cash flow and/or sector multiples, depending on the company) with a low–high range and a confidence label. Price vs fair value is the latest close divided by the central estimate, minus 1. The latest run in this list is from Nov 2, 2026.
Which French companies trade furthest from their ATLAS fair value?
As of Nov 3, 2026, among the companies listed, Renault has the largest gap below the model's central estimate (price -66% vs fair value) and Bollore the largest gap above (price +97%). These are model outputs, not recommendations.
Is this a recommendation to buy or sell?
No. This page is information only, not investment advice. ATLAS estimates come from statistical models using public data; they can be wrong, and past results do not guarantee future ones.
More on European stocks
- European dividend calendar
- Best dividend stocks in France
- Stocks below fair value in France
- All France stocks
- How ATLAS estimates fair value
- All stocks
Other countries
Information only, not investment advice. Disclaimer